PDF herunterladen
Synlett 2010(7): 1059-1062  
DOI: 10.1055/s-0029-1219557
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

First Total Syntheses of (+)-Garvensintriol and (+)-5-epi-Garvensintriol

Debendra K. Mohapatra*, B. Prem Kumar, K. Bhaskar, Jhillu S. Yadav*
Organic Chemistry Division I, Indian Institute of Chemical Technology (CSIR), Uppal Road, Hyderabad 500007, India
Fax: +91(40)27160512; e-Mail: mohapatra@iict.res.in;
Weitere Informationen

Publikationsverlauf

Received 24 December 2009
Publikationsdatum:
26. Februar 2010 (online)

   Lizenzen und Reprints Alle Artikel dieser Rubrik
Preview

Abstract

A concise and efficient carbohydrate-based approach for the total syntheses of (+)-garvensintriol and (+)-5-epi-garvensintriol is described in nine and six steps with 20% and 37% overall yield, respectively, starting from a known intermediate. A sequence of Grignard-assisted lactol opening with terminal alkyne, stereoselective keto reduction and oxidative lactonization are the key reactions.

Keywords

garvensintriol - goniotriol - cytotoxic - oxidative lactonization - Grignard-assisted lactol opening

    References and Notes

  • 1a Hoffmann HMR. Rabe J. Angew. Chem. Int. Ed.  1985,  24:  94 
    Suche in Google Scholar
  • 1b Negishi E. Kotora M. Tetrahedron Lett.  1997,  53:  6707 
    Suche in Google Scholar
  • 1c Collins I. J. Chem. Soc., Perkin Trans. 1  1999,  1377 
  • 1d Carter NB. Nadany AE. Sweeney JB. J. Chem. Soc., Perkin Trans. 1  2002,  2324 
  • 2a Davis-Coleman MT. Rivett DEA. Prog. Chem. Org. Nat. Prod.  1989,  55:  1 
    Suche in Google Scholar
  • 2b Dickinson JM. Nat. Prod. Rep.  1993,  10:  71 
    Suche in Google Scholar
  • 2c Collett LA. Davies-Coleman MT. Rivette DEA. Prog. Chem. Org. Nat. Prod.  1998,  75:  181 
    Suche in Google Scholar
  • 3a Chrusciel RA. Strohbach JW. Curr. Top. Med. Chem.  2004,  4:  1097 ; and references therein
    Suche in Google Scholar
  • 3b Chan KM. Rajab NF. Ishak NHA. Ali AM. Yusoff K. Din LB. Inayat-Hussain SH. Chem.-Biol. Interact.  2006,  159:  129 ; and references therein
    Suche in Google Scholar
  • 3c Newmeyer DD. Ferguson-Miller S. Cell  2003,  112:  481 ; and references therein
    Suche in Google Scholar
  • 3d Kikuchi H. Sasaki K. Sekiya J. Maeda Y. Amagai A. Kubohara Y. Ohsima Y. Bioorg. Med. Chem.  2004,  12:  3203 
    Suche in Google Scholar
  • 3e Richetti A. Fimiani V. Immunopharmacol. Immunotoxicol.  2003,  25:  441 
    Suche in Google Scholar
  • 4a Fang XP. Anderson JE. Qui XX. Kozlowski JF. Chang CJ. McLaughlin JL. Tetrahedron  1993,  49:  1563 
    Suche in Google Scholar
  • 4b Goh SH. Ee GCL. Chuah CH. Nat. Prod. Lett.  1995,  5:  255 
    Suche in Google Scholar
  • 4c McLaughlin JL. Chang CJ. Smith DL. In Human Medicinal Agents from Plants   Kinghorn AD. Baladrin A. American Chemical Society; Washington: 1993.  Vol. 534. p.112 
  • 5 Bermejo A. Blázquez MA. Rao KS. Cortes D. Phytochemistry  1998,  47:  135 
    CrossrefSuche in Google Scholar
  • 6 Alkofahi A. Ma WW. McKenzie AT. Byrn SR. McLaughlin JL. J. Nat. Prod.  1989,  52:  1371 
    CrossrefSuche in Google Scholar
  • 7 Koeski K. Ebata T. Matsushita H. Biosci. Biotech. Biochem.  1996,  60:  534 
    CrossrefSuche in Google Scholar
  • 8 Rycroft AD. Singh G. Wightman RH. J. Chem. Soc., Perkin Trans. 1  1995,  1667 
    Crossref
  • 9 Mitsunobu O. Synthesis  1981,  1 
    Thieme Connect
  • 10 Corey EJ. Schmidt G. Tetrahedron Lett.  1979,  399 
    Crossref
  • 11a Corey EJ. Bakshi RK. Shibata S. J. Am. Chem. Soc.  1987,  109:  5551 
    Suche in Google Scholar
  • 11b Corey EJ. Bakshi RK. Shibata S. Chen CP. Singh VK. J. Am. Chem. Soc.  1987,  109:  7925 
    Suche in Google Scholar
  • 11c Deloux L. Srebnik M. Chem. Rev.  1993,  93:  763 
    Suche in Google Scholar
  • 11d Corey EJ. Helal CJ. Angew. Chem. Int. Ed.  1998,  37:  1986 
    Suche in Google Scholar
  • 14 Hansen TM. Florence GJ. Lugo-Mas P. Chen J. Abrams JN. Forsyth CJ. Tetrahedron Lett.  2003,  44:  57 
    CrossrefSuche in Google Scholar
  • 16a Corey EJ. Gras JL. Ulrisch P. Tetrahedron Lett.  1976,  809 
  • 16b Bhatt MV. Kulkarni SV. Synthesis  1983,  249 
12

Analytical and Spectral Data of 8: white solid; mp 67 ˚C; [α]D ²5 +48.0 (c = 1.0, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.15-7.62 (m, 15 H), 4.60 (d, J = 6.0 Hz, 1 H), 4.46 (d, J = 13.6 Hz, 3 H), 4.29 (d, J = 11.3 Hz, 1 H), 3.96 (dd, J = 7.6, 2.7 Hz, 1 H), 3.48-3.72 (m, 4 H), 3.23 (br s, 1 H), 2.96 (br s, 1 H), 1.89 (br s, 1 H), 1.50-1.81 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.9, 137.5, 137.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.7, 83.2, 80.3, 74.3, 71.7, 71.5, 70.7, 62.6, 28.2, 24.9. MS (ESI): m/z = 437 [M + H]+.

13

Analytical and Spectral Data of 17: white solid; mp 139 ˚C; [α]D ²5 = -22.2 (c = 1.5, CHCl3). IR (neat): 3395, 3029, 2960, 2911, 2859, 1746, 1453, 1396, 1259, 1086, 1028, 761, 705 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.17-7.51 (m, 15 H), 4.31-4.59 (m, 5 H), 4.19 (d, J = 11.3 Hz, 1 H), 3.99-4.12 (m, 2 H), 2.56-2.79 (m, 1 H), 2.19-2.55 (m, 2 H), 1.93-2.16 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 171.2, 137.7, 137.2, 128.6, 128.5, 128.4, 128.3, 128.2, 127.8, 127.7, 127.7, 81.8, 81.0, 74.4, 70.7, 70.5, 69.7, 26.0, 22.7. MS (ESI): m/z = 455 [M + Na]+.

15

Analytical and Spectral Data of 2: white solid; mp 163 ˚C; [α]D ²5 -10.1 (c = 0.5, EtOH). IR (neat): 3533, 3346, 2923, 1773, 1200, 1083, 1026, 897, 850, 705, 673 cm-¹. ¹H NMR (300 MHz, CD3OD): δ = 7.07-7.51 (m, 5 H), 4.77 (m, 2 H), 4.60 (br s, 3 H), 3.65-3.78 (m, 2 H), 2.09-2.62 (m, 4 H). ¹H NMR (300 MHz, DMSO-d 6): δ = 7.12-7.53 (m, 5 H), 5.35 (dd, J = 13.8, 3.8 Hz, 2 H), 4.84 (d, J = 4.9 Hz, 1 H), 4.71 (s, 2 H), 3.44-3.66 (m, 2 H), 1.95-2.48 (m, 4 H). ¹³C NMR (75 MHz, CD3OD): δ = 180.8, 142.2, 129.9, 128.9, 128.6, 83.1, 76.4, 75.3, 73.4, 29.8, 21.8. MS (ESI): m/z = 275 [M + Na]+.

17

Crystallographic data for the structure in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 755246 for 17. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK [fax: +44 (1223)336033 or e-mail: deposit@ccdc.cam.ac.uk].

18

Analytical and Spectral Data of 7: white solid; mp 93 ˚C; [α]D ²5 +26.4 (c = 1.5, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.17-7.50 (m, 15 H), 4.40-4.64 (m, 4 H), 4.24 (d, J = 11.5 Hz, 1 H), 3.99 (t, J = 5.7 Hz, 1 H), 3.75 (t, J = 5.5 Hz, 1 H), 3.48 (t, J = 6.0 Hz, 2 H), 3.38 (d, J = 7.6 Hz, 1 H), 2.90 (br s, 3 H), 1.61-1.74 (m, 2 H), 1.38-1.52 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.9, 137.6, 137.5, 128.4, 128.3, 128.2, 128.0, 127.8, 82.6, 78.3, 74.3, 72.3, 72.0, 70.6, 62.5, 28.5, 26.5. MS (ESI): m/z = 437 [M + H]+.

19

Analytical and Spectral Data of 19: white solid; mp 127 ˚C; [α]D ²5 = +3.2 (c = 0.5, CHCl3). IR (neat): 3464, 3030, 2923, 1736, 1494, 1452, 1354, 1239, 1201, 1090, 1055, 741, 700, 579 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.20-7.54 (m, 15 H), 4.75 (d, J = 3.6 Hz, 1 H), 4.60 (d, J = 11.7 Hz, 1 H), 4.41-4.55 (m, 3 H), 4.31 (d, J = 11.3 Hz, 1 H), 3.95 (br s, 1 H), 3.74 (dd, J = 8.7, 1.5 Hz, 1 H), 2.58-2.76 (m, 1 H), 2.88 (br s, 1 H), 2.35-2.56 (m, 1 H), 2.78-2.15 (m, 1 H), 1.57-1.78 (m, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 169.9, 137.7, 137.5, 136.3, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 80.7, 80.5, 71.3, 71.1, 71.0, 68.2, 25.4, 23.0. MS (ESI): m/z = 455 [M + Na]+.

20

Analytical and Spectral Data of 1: [α]D ²5 +70.3 (c = 1.5, MeOH). IR (neat): 3396, 2921, 1756, 1453, 1371, 1270, 1195, 1079, 1043, 917, 815, 705, 578 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 7.28-7.51 (m, 5 H), 4.95 (t, J = 6.2 Hz, 1 H), 4.85 (d, J = 6.6 Hz, 1 H), 3.93 (t, J = 7.6 Hz, 1 H), 3.59 (dd, J = 7.9, 1.3 Hz, 1 H), 2.58-2.75 (m, 1 H), 2.39-2.56 (m, 1 H), 2.14-2.38 (m, 2 H), 1.71 (br s, 2 H). ¹³C NMR (75 MHz, CD3OD): δ = 180.9, 142.2, 128.6, 128.9, 129.1, 81.3, 76.6, 75.6, 74.4, 29.5, 24.4. MS (ESI): m/z = 253 [M + H]+.